https://doi.org/10.4081/monaldi.2024.2852
Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort
Published: January 11, 2024
Abstract Views: 358
PDF_EARLY VIEW: 223
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Tuberculosis (TB) diagnosis and management in special populations remain challenging. Data about TB and transgender individuals is scarce, and strategies aimed at reducing the TB burden in this at-risk group are needed. We conducted an observational monocentric study from a national reference center for TB, including transgender individuals with active TB in a low-TB burden country (Italy), over 34 years (1990-2023). Sixty-six transgender males and two transgender females (median age 30 years, interquartile range 26-38 years, 65 migrants) were included. Most patients (38/66, 57.6%) lived in poor social conditions. 65.2% (43/66) of patients were people living with HIV. Multidrug- and rifampicin-resistant tuberculosis and isoniazid-resistant TB were diagnosed in five (7.6%) and three (4.5%) patients, respectively. The overall treatment success rate was 72.7% (48/66 patients), with differences observed according to social conditions. Our study highlights the need for a tailored approach to increase treatment success in this at-risk population.
World Health Organization. Global tuberculosis report 2022. Available from: https://iris.who.int/bitstream/handle/10665/363752/9789240061729-eng.pdf?sequence=1.
Matucci T, Riccardi N, Occhineri S, et al. Treatment of latent tuberculosis infection in incarcerated people: a systematic review. Clin Microbiol Infect 2023;29:714-21.
DOI: https://doi.org/10.1016/j.cmi.2023.02.016
Riccardi N, Antonello RM, Ferrarese M, et al. Tuberculosis in migrants: epidemiology, resistance and outcome in Milan, Italy. Infect Dis 2023;55:543-50.
DOI: https://doi.org/10.1080/23744235.2023.2217912
Shah SA, Qayyum S, Baig S, et al. Results of community-based TB and HIV screening among transgender women and male sex workers in Pakistan. PLOS Glob Public Health 2023;3:e0000913.
DOI: https://doi.org/10.1371/journal.pgph.0000913
Pareek M, Greenaway C, Noori T, et al. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med 2016;14:48.
DOI: https://doi.org/10.1186/s12916-016-0595-5
Commission of the European Communities. Commission decision of 28 April 2008 amending decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under decision no 2119/98/EC of the European Parliament and of the Council. In: Official Journal, L159/46, 18/06/2008.
Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent mycobacterium tuberculosis infection. N Engl J Med 2015;372:2127-35.
DOI: https://doi.org/10.1056/NEJMra1405427
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Available from: https://iris.who.int/bitstream/handle/10665/365308/9789240063129-eng.pdf?sequence=1.
Canetti D, Antonello RM, Saderi L, et al. Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey. Infez Med 2022;30:418-26.
DOI: https://doi.org/10.53854/liim-3003-10
Morrison H, Perrin F, Dedicoat M, et al. Impact of COVID-19 on NHS tuberculosis services: Results of a UK-wide survey. J Infect 2023;87:59-61.
DOI: https://doi.org/10.1016/j.jinf.2023.04.004
Ethics Approval
The study received ethical approval n. 578–112,018 from the ethical committee of ASST Niguarda Ca′ Granda in Milan (Italy) and it was conducted in agreement with the Declaration of Helsinki (1964) and its later amendments.How to Cite
Riccardi, Niccolò, Roberta Maria Antonello, Maurizio Ferrarese, Alice Repossi, Laura Saderi, Giovanni Fumagalli, Giorgio Besozzi, Giovanni Sotgiu, and Luigi Codecasa. 2024. “Tailored Treatment for Tuberculosis in Transgender Individuals: A Call for a Patient-Centered Approach from a Large Italian Cohort”. Monaldi Archives for Chest Disease, January. https://doi.org/10.4081/monaldi.2024.2852.
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Maria Vincenza Polito, Mario Ferraioli, Alessandra Nocilla, Guido Coppola, Federica D’Auria, Antonio Marzano, Luca Barnabei, Marisa Malinconico, Eduardo Bossone, Francesco Ferrara, CHARGE syndrome and congenital heart diseases: systematic review of literature , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria, Tuberculosis endemicity and BCG vaccination: Protection against COVID-19 , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Christian Auer, Rais Mazitov, Alisher Makhmudov, Bobojon Pirmahmadzoda, Alena Skrahina, Andrei Dobre, Florence Sécula, Xavier Bosch-Capblanch, Martin van den Boom, Giovanni Battista Migliori, Nino Mdivani, Mohammed A. Yassin, Factors contributing to drug-resistant tuberculosis treatment outcome in five countries in the Eastern Europe and Central Asia region , Monaldi Archives for Chest Disease: Vol. 90 No. 1 (2020)
- Syed Muhammad Zubair, Mariyam Gohar Ali, Muhammad Irfan, Post tuberculosis radiological sequelae in patients treated for pulmonary and pleural tuberculosis at a tertiary center in Pakistan , Monaldi Archives for Chest Disease: Vol. 92 No. 1 (2022)
- Grazia Mazzeo, Luigi Aronne, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Francesco Saverio Cerqua, Carlo Iadevaia, Adriano Costigliola, Roberto Parrella, Andrea Bianco, Vanvitelli/Monaldi COVID Group, Which impact for proton pump inhibitors in SARS-CoV-2 pneumonia , Monaldi Archives for Chest Disease: Vol. 91 No. 4 (2021)
- Karrar Al-Buthabhak , Hussein Nafakhi, Mohammed H. Shukur , Ahmed Nafakhi, Mohammed Alareedh, Foaad Shaghee, Blood indices, in-hospital outcome and short-term prognosis in patients with COVID-19 pneumonia , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Ravindra Nath, Nitin Panwar, Aninda Debnath, Anirban Bhaumik, Jugal Kishore, Pranav Ish, Prevalence of tuberculosis among healthcare workers in India: a systematic review and meta-analysis , Monaldi Archives for Chest Disease: Early Access
- Rakhi Gaur, Suresh Kumar Sharma, Suman Kumar, Shiv Kumar Mudgal, Vipin Patidar, Ayesha Juhi, Knowledge, attitude and perceived barriers related to directly observed treatment, short-course among patients and caregivers attending tuberculosis clinics: a cross-sectional survey , Monaldi Archives for Chest Disease: Early Access
- Alberto M. Marra, Andrea Salzano, Michele Arcopinto, Lucrezia Piccioli, Valeria Raparelli, The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Nitin Goel, Nitesh Goyal, Raj Kumar, Clinico-radiological evaluation of post COVID-19 at a tertiary pulmonary care centre in Delhi, India , Monaldi Archives for Chest Disease: Vol. 91 No. 3 (2021)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
You may also start an advanced similarity search for this article.
